Onsite QTc Interval Screening for Patients in Methadone Maintenance Treatment

REFERENCES

• Johnson , R E , Chutuape , M A , Strain , E C , Walsh , S L , Stitzer , H L and Bigelow , G E . 2000 . A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence . N Engl J Med , 343 : 1290 – 7 .
   PubMed Web of Science ®Google Scholar
• Rhoades , H M , Creson , D , Elk , R , Schmitz , J and Grabowski , J . 1998 . Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency . Am J Public Health , 88 : 34 – 9 .
   PubMed Web of Science ®Google Scholar
• Preston , K L , Umbricht , A and Epstein , D H . 2000 . Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance . Arch Gen Psychiatry , 57 : 395 – 404 .
   PubMed Web of Science ®Google Scholar
• Dole , V P and Nyswander , M . 1965 . A medical treatment for diacetylmorphine (heroin) addiction: a clinical trial with methadone hydrochloride . JAMA , 193 : 80 – 4 .
   Web of Science ®Google Scholar
• Dole , V P and Nyswander , M E . 1966 . Rehabilitation of heroin addicts after blockade with methadone . N Y State J Med , 66 : 2011 – 7 .
   PubMedGoogle Scholar
• Marsch , LA . 1998 . The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior, and criminality: a meta-analysis . Addiction , 93 : 515 – 32 .
   PubMed Web of Science ®Google Scholar
• Zanis , D A and Woody , G E . 1998 . One-year mortality rates following methadone treatment discharge . Drug Alcohol Depend , 52 : 257 – 60 .
   PubMed Web of Science ®Google Scholar
• Woody , G E , Kane , V , Lewis , K and Thompson , R . 2007 . Premature deaths after discharge from methadone maintenance: a replication . J Addict Med , 1 : 180 – 5 .
   PubMed Web of Science ®Google Scholar
• Routhier , D D , Katz , K D and Brooks , D E . 2007 . QTc prolongation and Torsades De Pontes associated with methadone therapy . J Emer Med , 32 : 275 – 8 .
   PubMed Web of Science ®Google Scholar
• Krantz , M , Lewkowiez , L , Hays , H , Woodroffe , M A , Robertson , A D and Mehler , P S . 2002 . Torsade de pointes associated with very-high-dose methadone . Ann Intern Med , 137 : 501 – 4 .
   PubMed Web of Science ®Google Scholar
• Cruciani , R A . 2008 . Methadone: to ECG or not to ECG…that is still the question . J Pain Symptom Manage , 36 : 545 – 52 .
   PubMed Web of Science ®Google Scholar
• Bednar , M M , Harrigan , E P Anziano , R J . 2001 . The Q T interval . Prog Cardiovas Dis , 431 : 1 – 45 .
   Google Scholar
• Tan , H L , Hou , C J , Lauer , M R and Sung , R J . 1995 . Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes . Ann Internal Med , 122 : 701 – 714 .
   PubMed Web of Science ®Google Scholar
• Wedam , E F , Bigelow , G E , Johnson , R E , Nuzzo , P A and Haigney , M C . 2007 . QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial . Arch Intern Med , 167 : 2469 – 75 .
   PubMed Web of Science ®Google Scholar
• Latowsky , M . 2006 . Methadone death, dosage, and torsade de pointes: risk-benefit policy implications . J Psychoactive Drugs , 38 : 513 – 9 .
   PubMed Web of Science ®Google Scholar
• Roden , D M . 2004 . Drug-induced prolongation of the QT interval . N Eng J Med , 350 ( 1 ) : 1013 – 22 .
   PubMedGoogle Scholar
• Huffman , J C and Stern , T A . 2003 . QTc prolongation and the use of antipsychotics: a case discussion . Primary Care Companion J Clin Psychiatry , 5 : 96
   Google Scholar
• Vieweg , W VR . 2003 . New generation antipsychotic drugs and QTc internval prolongation . Primary Care Companion J Clin Psychiatry , 5 ( 5 ) : 205 – 15 .
   PubMedGoogle Scholar
• Zareba , W . 2007 . Drug induced QT prolongation . Cardiol J , 14 : 523 – 33 .
   PubMedGoogle Scholar
• Peles , E , Bodner , G , Kreek , M J , Rados , V and Adelson , M . 2007 . Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study . Addiction , 102 : 289 – 300 .
   PubMed Web of Science ®Google Scholar
• Kornick , C A , Kilborn , M J , Santiago-Palma , J , Schulman , G , Thaler , H T , Keefe , D L , Katchman , A N , Pezzullo , J C , Ebert , S N , Woosley , R L , Payne , R and Manfredi , P L . 2003 . QTc interval prolongation associated with intravenous methadone . Pain , 105 : 499 – 506 .
   PubMed Web of Science ®Google Scholar
• Maremmani , I , Pacini , M , Cesaroni , C , Lovrecic , M , Perugi , G and Tagliamonte , A . 2005 . QTc interval prolongation in patients on long-term methadone maintenance therapy . Eur Addict Res , 11 : 44 – 9 .
   PubMed Web of Science ®Google Scholar
• Ehret , G B , Voide , C , Gex-Fabry , M , Chabert , J , Shah , D , Broers , B , Pisuet , V , Musset , T , Gaspoz , J M , Perrier , A , Dayer , P and Desmeules , J A . 2006 . Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors . Arch Intern Med , 166 : 1280 – 7 .
   PubMed Web of Science ®Google Scholar
• Fanoe , S , Hvidt , C , Ege , P and Jensen , G B . 2007 . Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen . Heart , 93 : 1051 – 5 .
   PubMed Web of Science ®Google Scholar
• Cruciani , R A , Sekine , R , Homel , P , Lussier , D , Yap , Y , Suzuki , Y , Schweitzer , P , Yancovitz , S R , Lapin , J A , Shaiova , L , Sheu , R G and Portenoy , R K . 2005 . Measurement of QTc in patients receiving chronic methadone therapy . J Pain Symptom Manage , 29 : 385 – 91 . [PMID: 15857742]
   PubMed Web of Science ®Google Scholar
• Martell , B A , Arnsten , J H , Krantz , M J and Gourevitch , M N . 2005 . Impact of methadone treatment on cardiac repolarization and conduction in opioid users . Am J Cardiol , 95 : 915 – 8 .
   PubMed Web of Science ®Google Scholar
• Krantz , M J , Kutinsky , I B , Robertson , A D and Mehler , P S . 2003 . Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes . Pharmacotherapy , 23 : 802 – 5 .
   PubMed Web of Science ®Google Scholar
• Committee for Proprietary Medicinal Products . 1997 . Points to consider: the assessment of the potential for QT interval prolongation by non-cardiovascular medicinal products , London : The European Agency for the Evaluation of Medicinal Products .
   Google Scholar
• U.S. Food and Drug Administration . 2005 . Guidance for industry: E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs , Rockville, MD : Center for Drug Evaluation and Research .
   Google Scholar
• Bednar , M M , Harrigan , E P and Ruskin , J N . 2002 . Torsades de pointes associated with nonantiarrhythmic drugs and observations on gender and QTc . Am J Cardiol , 89 : 1316 – 9 .
   PubMed Web of Science ®Google Scholar
• http://www.fda.gov/CDER/drug/advisory/methado-ne.htm(accessed 1/9/09)
   Google Scholar
• 2006 . Dolophine Hydrochloride CII (Methadone Hydrochloride Tablets, USP) 5 mg, 10 mg, Rx Only , Columbus, OH : Roxane Laboratories . www.fda.gov/cder/foi/label/2006/006134s028lbl.pdf(accessed November 12, 2008)
   Google Scholar
• 2003 . Product Discontinuation Notice: Orlaam (Levomethadyl Hydrochloride Acetate) Oral Solution, 10 mg/mL, CII , Columbus, OH : Roxane Laboratories . www.fda.gov/cder/drug/shortages/orlaam.htm(accessed November 12, 2008)
   Google Scholar
• Krantz , M J , Martin , J , Stimmel , B , Mehta , D and Haigney , M CP . 2009 . QTc interval screening in methadone treatment . Ann Intern Med , 150 : 387 – 95 .
   PubMed Web of Science ®Google Scholar
• Fareed , A , Casarella , J , Amar , R , Vayalapalli , S and Drexler , K . 2009 . Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts . J Psych Pract , 15 : 227 – 34 .
   PubMed Web of Science ®Google Scholar
• Ling , W , Charuvastra , V C , Kaim , S C and Klett , C J . 1976 . Methadyl acetate and methadone as maintenance treatments for heroin addicts: a Veterans Administration cooperative study . Arch Gen Psychiatry , 33 : 709 – 20 .
   PubMed Web of Science ®Google Scholar
• Strain , E C , Stitzer , M L , Liebson , I A and Bigelow , G E . 1993 . Dose-response effects of methadone in the treatment of opioid dependence . Ann Intern Med , 119 : 23 – 7 .
   PubMed Web of Science ®Google Scholar
• Chiang , C E and Roden , D M . 2000 . The long QT syndromes: genetic basis and clinical implications . J Am Coll Cardiol , 36 : 1 – 12 .
   PubMed Web of Science ®Google Scholar
• Katchman , A N , McGroary , K A , Kilborn , M J , Kornick , C A , Manfredi , P L , Woosley , R L and Ebert , S N . 2002 . Influence of opioid agonists on cardiac human ether-a-go-gorelated gene K(_) currents . J Pharmacol Exp Ther , 303 : 688 – 94 .
   PubMed Web of Science ®Google Scholar
• Ferreira , S , Crumb , W J Jr. , Carlton , C G and Clarkson , C W . 2001 . Effects of cocaine and its major metabolites on the HERG-encoded potassium channel . J Pharmacol Exp Ther , 299 : 220 – 6 .
   PubMed Web of Science ®Google Scholar